Erasca, Inc. (NASDAQ:ERAS) has 148 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 31 Dec, 2025 | 22,729,436 | 0 | 0.00% | $84,553,502.00 |
| T. Rowe Price Investment Management, Inc. | 31 Dec, 2025 | 20,898,239 | 666,333 | 3.29% | $77,742.00 |
| VR Adviser, LLC | 31 Dec, 2025 | 17,857,083 | 0 | 0.00% | $66,428,349.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 15,597,330 | 526,011 | 3.49% | $58,022,066.00 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 14,502,004 | 0 | 0.00% | $53,947,455.00 |
| Paradigm Biocapital Advisors LP | 31 Dec, 2025 | 14,159,095 | 599,078 | 4.42% | $52,671,833.00 |
| Logos Global Management LP | 31 Dec, 2025 | 13,000,000 | -2,150,000 | -14.19% | $48,360,000.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 12,812,156 | 324 | 0.00% | $47,661,220.00 |
| ARCH Venture Management, LLC | 31 Dec, 2025 | 11,055,554 | 0 | 0.00% | $41,126,661.00 |
| Vivo Capital, LLC | 31 Dec, 2025 | 9,273,428 | 0 | 0.00% | $34,497,152.00 |
| Siren, L.L.C. | 31 Dec, 2025 | 8,757,249 | 0 | 0.00% | $32,576,966.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 6,662,836 | 4,145,648 | 164.69% | $24,785,750.00 |
| State Street Corp | 31 Dec, 2025 | 6,174,642 | 2,145,386 | 53.25% | $22,969,668.00 |
| 5AM Venture Management, LLC | 31 Dec, 2025 | 5,405,404 | 0 | 0.00% | $20,108,103.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 4,926,335 | 77,772 | 1.60% | $18,330,444.00 |
| Affinity Asset Advisors, LLC | 31 Dec, 2025 | 3,900,000 | -385,787 | -9.00% | $14,508,000.00 |
| Spruce Street Capital LP | 31 Dec, 2025 | 3,889,632 | 3,889,632 | 0.00% | $14,469,431.00 |
| a16z Capital Management, L.L.C. | 31 Dec, 2025 | 2,862,500 | 0 | 0.00% | $10,648,500.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 2,237,951 | -676,868 | -23.22% | $8,325,178.00 |
| Soleus Capital Management, L.P. | 31 Dec, 2025 | 2,162,162 | 0 | 0.00% | $8,043,243.00 |